300636 Stock Overview
Manufactures and sells APIs worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 300636 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Jiangxi Synergy Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.45 |
| 52 Week High | CN¥11.50 |
| 52 Week Low | CN¥5.76 |
| Beta | -0.085 |
| 1 Month Change | -3.21% |
| 3 Month Change | 23.18% |
| 1 Year Change | -19.83% |
| 3 Year Change | -46.52% |
| 5 Year Change | 16.47% |
| Change since IPO | 55.70% |
Recent News & Updates
Recent updates
Jiangxi Synergy Pharmaceutical Co., Ltd. (SZSE:300636) Stock Rockets 43% But Many Are Still Ignoring The Company
Oct 08
Is Jiangxi Synergy Pharmaceutical (SZSE:300636) A Risky Investment?
Jun 28Jiangxi Synergy Pharmaceutical's (SZSE:300636) Profits Appear To Have Quality Issues
May 01Jiangxi Synergy Pharmaceutical Co., Ltd.'s (SZSE:300636) 41% Share Price Surge Not Quite Adding Up
Apr 27Shareholder Returns
| 300636 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.2% | -1.9% | -1.2% |
| 1Y | -19.8% | -1.8% | 11.8% |
Return vs Industry: 300636 underperformed the CN Pharmaceuticals industry which returned -1.8% over the past year.
Return vs Market: 300636 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 300636 volatility | |
|---|---|
| 300636 Average Weekly Movement | 8.3% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300636 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300636's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 1,362 | Zhengwei Pang | www.jxsynergy.com |
Jiangxi Synergy Pharmaceutical Co., Ltd. manufactures and sells APIs worldwide. It offers raw materials, pharmaceutical intermediates, and fine chemicals. Jiangxi Synergy Pharmaceutical Co., Ltd.
Jiangxi Synergy Pharmaceutical Co., Ltd. Fundamentals Summary
| 300636 fundamental statistics | |
|---|---|
| Market cap | CN¥3.53b |
| Earnings (TTM) | CN¥123.07m |
| Revenue (TTM) | CN¥732.41m |
28.7x
P/E Ratio4.8x
P/S RatioIs 300636 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300636 income statement (TTM) | |
|---|---|
| Revenue | CN¥732.41m |
| Cost of Revenue | CN¥495.31m |
| Gross Profit | CN¥237.10m |
| Other Expenses | CN¥114.04m |
| Earnings | CN¥123.07m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.29 |
| Gross Margin | 32.37% |
| Net Profit Margin | 16.80% |
| Debt/Equity Ratio | 32.3% |
How did 300636 perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield14%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 08:53 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiangxi Synergy Pharmaceutical Co., Ltd. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kai Wang | Citic Securities Co., Ltd. |
| Xiao Wei Lin | Everbright Securities Co. Ltd. |
| Jiaxi Xu | Industrial Securities Co. Ltd. |